More than 200 proteins associate with human spliceosomes, but little is known about their relative abundances in a given spliceosomal complex. Here we describe a novel two-dimensional (2D) electrophoresis method that allows separation of high-molecular-mass proteins without in-gel precipitation and thus without loss of protein. Using this system coupled with mass spectrometry, we identified 171 proteins altogether on 2D maps of stage-specific spliceosomal complexes. By staining with a fluorescent dye with a wide linear intensity range, we could quantitate and categorize proteins as present in high, moderate, or low abundance. Affinitypurified human B, B act , and C complexes contained 69, 63, and 72 highly/moderately abundant proteins, respectively. The recruitment and release of spliceosomal proteins were followed based on their abundances in A, B, B act , and C spliceosomal complexes. Staining with a phospho-specific dye revealed that approximately one-third of the proteins detected in human spliceosomal complexes by 2D gel analyses are phosphorylated. The 2D gel electrophoresis system described here allows for the first time an objective view of the relative abundances of proteins present in a particular spliceosomal complex and also sheds additional light on the spliceosome's compositional dynamics and the phosphorylation status of spliceosomal proteins at specific stages of splicing.The spliceosome is a highly complex and dynamic megadalton RNP machine. It is comprised of the five snRNPs U1, U2, U4, U5, and U6 and a large number of non-snRNP protein factors (reviewed in reference 42). Spliceosomes assemble de novo in a stepwise manner on each new intron to be spliced and thus pass through a series of distinct complexes (42). Initially, the U1 snRNP binds the pre-mRNA, forming the E complex, and after stable U2 snRNP interaction, the A complex is generated. Subsequently, the U4/U6 and U5 snRNPs associate, as part of the U4/U6.U5 tri-snRNP, and the precatalytic B complex is formed. Through a series of compositional and structural rearrangements, the B complex is activated, first yielding the B act complex. After the action of the DEXH box protein Prp2, the B* complex is formed, which catalyzes step 1 of splicing. This involves cleavage at the 5Đ splice site (ss) of the pre-mRNA and the ligation of the 5Đ end of the intron to the so-called branch site to form a lariat-like structure. After the first step, the spliceosomal C complex is formed, and it catalyzes the step 2 of splicing, during which the intron is excised and the exons are ligated together to form mRNA.Mass spectrometry (MS) analyses have shown that more than 200 proteins copurify with mixtures of human spliceosomal complexes (31, 47). Individual spliceosomal complexes contain many fewer proteins (e.g., Ïł125 for B, B act , and C complexes) and differ from each other considerably in composition (3,6,7,10). However, the relative abundances of all of the proteins present within a given spliceosomal complex are presently not clear. Spliceosomes contain...